Repertoire Immune Medicines is a clinical-stage biotechnology company working to unlock and direct the remarkable power of the human immune system to prevent or treat cancer, as well as autoimmune and infectious disease.
View all
Allakos
San Carlos, United States · Post IPO Equity
TwinStrand Biosciences
Seattle, United States · Series B
Erasca
San Diego, United States · Post IPO Equity
Korro Bio
Cambridge, United States · Series B
Sonoma Biotherapeutics
South San Francisco, United States · Corporate Round
ShapeTX
Seattle, United States · Series B
Verve Therapeutics
Cambridge, United States · IPO
Sherlock Biosciences
Boston, United States · Grant
Entrada Therapeutics
Boston, United States · Post IPO Equity
StrideBio
Durham, United States · Series B
AVROBIO
Cambridge, United States · IPO
Neon Therapeutics
Cambridge, United States · IPO